Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bram Verstockt

Showing results (71-80 of 167) with videos related to

Pageof 17
Sort By:
BMJ Open Gastroenterology|September 29, 2025
Development and validation of the FR-QoL-29-Dutch (Flemish) Questionnaire and assessment of clinical factors associated with food-related quality of life in a Belgian inflammatory bowel disease population: a cross-sectional studyJudith Wellens, Livia Guadagnoli, Julie Vanderstappen, et al.
Inflammatory Bowel Diseases|June 30, 2025
Unraveling Genetic Versus Environmental Factors Determining Disease Course in Inflammatory Bowel Diseases: A Population-Based Cohort Study in First- and Second-Generation ImmigrantsAnna-Teresa D'Hooghe, Gry Juul Poulsen, Christian Nikolai Sørensen, et al.
Journal of Crohn'S & Colitis|March 6, 2024
Disease Acceptance, but not Perceived Control, is Uniquely Associated with Inflammatory Bowel Disease-related DisabilityAnouk Teugels, Ilse van den Eijnden, Bep Keersmaekers, et al.
Ebiomedicine|January 28, 2019
Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel diseaseBram Verstockt, Sare Verstockt, Jonas Dehairs, et al.
Journal of Crohn'S & Colitis|September 10, 2015
A Matrix-based Model Predicts Primary Response to Infliximab in Crohn's DiseaseThomas Billiet, Konstantinos Papamichael, Magali de Bruyn, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2019
Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn's diseaseBram Verstockt, Sare Verstockt, Brecht Creyns, et al.
Journal of Crohn'S & Colitis|September 11, 2020
Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in ColonBram Verstockt, Sare Verstockt, Saeed Abdu Rahiman, et al.
Gastroenterology|December 14, 2023
Dysbiosis and Associated Stool Features Improve Prediction of Response to Biological Therapy in Inflammatory Bowel DiseaseClara Caenepeel, Gwen Falony, Kathleen Machiels, et al.
Inflammatory Bowel Diseases|February 10, 2026
Immunometabolism as a New Bimodal Therapeutic Concept in Inflammatory Bowel Disease and Immune-Mediated Inflammatory DisordersVirginia Solitano, Laurent Peyrin-Biroulet, Severine Vermeire, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2019
Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel DiseasesBram Verstockt, Sare Verstockt, Marisol Veny, et al.
Pageof 17

Showing results (71-80 of 167) with videos related to

Sort By:
Pageof 17
BMJ Open Gastroenterology|September 29, 2025
Development and validation of the FR-QoL-29-Dutch (Flemish) Questionnaire and assessment of clinical factors associated with food-related quality of life in a Belgian inflammatory bowel disease population: a cross-sectional studyJudith Wellens, Livia Guadagnoli, Julie Vanderstappen, et al.
Inflammatory Bowel Diseases|June 30, 2025
Unraveling Genetic Versus Environmental Factors Determining Disease Course in Inflammatory Bowel Diseases: A Population-Based Cohort Study in First- and Second-Generation ImmigrantsAnna-Teresa D'Hooghe, Gry Juul Poulsen, Christian Nikolai Sørensen, et al.
Journal of Crohn'S & Colitis|March 6, 2024
Disease Acceptance, but not Perceived Control, is Uniquely Associated with Inflammatory Bowel Disease-related DisabilityAnouk Teugels, Ilse van den Eijnden, Bep Keersmaekers, et al.
Ebiomedicine|January 28, 2019
Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel diseaseBram Verstockt, Sare Verstockt, Jonas Dehairs, et al.
Journal of Crohn'S & Colitis|September 10, 2015
A Matrix-based Model Predicts Primary Response to Infliximab in Crohn's DiseaseThomas Billiet, Konstantinos Papamichael, Magali de Bruyn, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2019
Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn's diseaseBram Verstockt, Sare Verstockt, Brecht Creyns, et al.
Journal of Crohn'S & Colitis|September 11, 2020
Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in ColonBram Verstockt, Sare Verstockt, Saeed Abdu Rahiman, et al.
Gastroenterology|December 14, 2023
Dysbiosis and Associated Stool Features Improve Prediction of Response to Biological Therapy in Inflammatory Bowel DiseaseClara Caenepeel, Gwen Falony, Kathleen Machiels, et al.
Inflammatory Bowel Diseases|February 10, 2026
Immunometabolism as a New Bimodal Therapeutic Concept in Inflammatory Bowel Disease and Immune-Mediated Inflammatory DisordersVirginia Solitano, Laurent Peyrin-Biroulet, Severine Vermeire, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2019
Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel DiseasesBram Verstockt, Sare Verstockt, Marisol Veny, et al.
Pageof 17